This project aims to develop effective therapeutic
products against emerging and re-emerging infectious diseases that are of
great priority in Thailand through the international alliance collaborative research
between the Department of Medical Sciences (DMSc), Ministry of Public Health
(MoPH), Thailand and the Research Institute for Microbial Diseases
(RIMD), Osaka University (OU), Japan. In addition, the Faculty of Tropical medicine (FTM), Mahidol University (MU), faculty of Science (FS), MU, International Center for Biotechnology (ICB), OU, and Medical and Biological Laboratories Co., LTD (MBL) are invovled in this project.
This project concentrates in two lines: the first mainly concerns the development of human monoclonal antibodies (MAb) and the second covers the development of therapeutic candidates from microorganisms that are prevalent in Thailand.
These developed agents are expected to be candidates with great effectiveness against infections with dengue virus as well as influenza virus and botulinum toxin. The successful candidates would be practically applied thereafter to clinical usage in Thailand.